SBI Pharmaceuticals and TAGCyx ANNOUNCES A MILESTONE ACHIEVEMENT OF THE RESEARCH AND DEVELOPMENT COLLABORATION OF INNOVATIVE CANCER THERAPY
SBI Pharmaceuticals Co., Ltd. and TAGCyx Biotechnologies Inc. are pleased to announce that progress has been made in the research and development collaboration to develop innovative products in the field of cancer treatment carried out by the two companies.
Please refer to the following for details. ENG Joint PR